1. Home
  2. TECX vs DMRC Comparison

TECX vs DMRC Comparison

Compare TECX & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • DMRC
  • Stock Information
  • Founded
  • TECX 2019
  • DMRC 2008
  • Country
  • TECX United States
  • DMRC United States
  • Employees
  • TECX N/A
  • DMRC N/A
  • Industry
  • TECX
  • DMRC EDP Services
  • Sector
  • TECX
  • DMRC Technology
  • Exchange
  • TECX Nasdaq
  • DMRC Nasdaq
  • Market Cap
  • TECX 334.4M
  • DMRC 275.4M
  • IPO Year
  • TECX 2018
  • DMRC N/A
  • Fundamental
  • Price
  • TECX $21.09
  • DMRC $13.53
  • Analyst Decision
  • TECX Buy
  • DMRC Strong Buy
  • Analyst Count
  • TECX 6
  • DMRC 1
  • Target Price
  • TECX $78.67
  • DMRC $30.00
  • AVG Volume (30 Days)
  • TECX 243.5K
  • DMRC 136.3K
  • Earning Date
  • TECX 08-13-2025
  • DMRC 08-12-2025
  • Dividend Yield
  • TECX N/A
  • DMRC N/A
  • EPS Growth
  • TECX N/A
  • DMRC N/A
  • EPS
  • TECX N/A
  • DMRC N/A
  • Revenue
  • TECX N/A
  • DMRC $37,848,000.00
  • Revenue This Year
  • TECX N/A
  • DMRC N/A
  • Revenue Next Year
  • TECX N/A
  • DMRC $4.21
  • P/E Ratio
  • TECX N/A
  • DMRC N/A
  • Revenue Growth
  • TECX N/A
  • DMRC 2.44
  • 52 Week Low
  • TECX $13.70
  • DMRC $10.44
  • 52 Week High
  • TECX $61.07
  • DMRC $48.32
  • Technical
  • Relative Strength Index (RSI)
  • TECX 50.45
  • DMRC 55.03
  • Support Level
  • TECX $19.13
  • DMRC $12.83
  • Resistance Level
  • TECX $20.75
  • DMRC $13.25
  • Average True Range (ATR)
  • TECX 1.33
  • DMRC 0.61
  • MACD
  • TECX -0.10
  • DMRC 0.06
  • Stochastic Oscillator
  • TECX 56.73
  • DMRC 76.04

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

Share on Social Networks: